Yifeng Pharmacy Chain Co., Ltd. (603939.SS)
CNY 25.67
(-0.62%)
CNY 25.67
(-0.62%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 133.61 Million CNY | -93.87% |
| 2022 | 2.17 Billion CNY | -8.79% |
| 2021 | 2.38 Billion CNY | 20.91% |
| 2020 | 1.97 Billion CNY | 187.62% |
| 2019 | 687.15 Million CNY | -7.74% |
| 2018 | 744.8 Million CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 1.88 Billion CNY | -2.77% |
| 2024 Q1 | 1.69 Billion CNY | 1169.66% |
| 2024 Q2 | 1.7 Billion CNY | 0.73% |
| 2023 Q3 | 2.12 Billion CNY | 0.36% |
| 2023 Q4 | 133.61 Million CNY | -93.71% |
| 2023 FY | 133.61 Million CNY | -93.87% |
| 2023 Q1 | 2.03 Billion CNY | -6.58% |
| 2023 Q2 | 2.11 Billion CNY | 3.87% |
| 2022 Q4 | 2.17 Billion CNY | -7.3% |
| 2022 Q3 | 2.35 Billion CNY | -2.74% |
| 2022 Q1 | 2.27 Billion CNY | -5.0% |
| 2022 Q2 | 2.41 Billion CNY | 6.5% |
| 2022 FY | 2.17 Billion CNY | -8.79% |
| 2021 Q1 | 2.52 Billion CNY | 27.67% |
| 2021 Q4 | 2.38 Billion CNY | -0.25% |
| 2021 Q3 | 2.39 Billion CNY | -8.77% |
| 2021 FY | 2.38 Billion CNY | 20.91% |
| 2021 Q2 | 2.62 Billion CNY | 4.07% |
| 2020 Q1 | 687.27 Million CNY | 0.02% |
| 2020 FY | 1.97 Billion CNY | 187.62% |
| 2020 Q3 | 1.99 Billion CNY | -2.24% |
| 2020 Q4 | 1.97 Billion CNY | -0.7% |
| 2020 Q2 | 2.03 Billion CNY | 196.23% |
| 2019 FY | 687.15 Million CNY | -7.74% |
| 2019 Q4 | 687.15 Million CNY | 0.17% |
| 2019 Q3 | 686 Million CNY | -7.89% |
| 2019 Q2 | 744.8 Million CNY | 0.0% |
| 2019 Q1 | 744.8 Million CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q4 | 744.8 Million CNY | 130.95% |
| 2018 Q3 | 322.5 Million CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 744.8 Million CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 107.24 Million CNY | -24.592% |
| Jointown Pharmaceutical Group Co., Ltd | 2.31 Billion CNY | 94.221% |
| LBX Pharmacy Chain Joint Stock Company | 1.37 Billion CNY | 90.306% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 1.94 Billion CNY | 93.148% |